ArticleCase reports in oncology

Durable and Drastic Response to the Trastuzumab, Letrozole, Abemaciclib, and Goserelin Combination as First-Line Therapy in HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer: A Case Report.

Suthida Suwanvecho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.